Member Info for TorquayFan

C11 - I did get in (and I couldnt copy it either). I normally work from Yahoo with an 'Adblocker' but I copied the link from Marcus onto Google (no adblock) and it worked. Interesting indeed - but just a little bang, on the 'off the shelf' drum. More please.

Yes troublesome. All you had to do was copy. the content as I asked. Thanks for nothing.

Irrespective of this glitch, I still think the new website is clumsy.

C11 - yes troublesome. And no, not 'user error' - maybe something on my laptop.

This is the link from Marcus 18532 I referred to https://scancell.co.uk/wp-content/uploads/2025/04/Cancer-Vaccines-Improve-Their-Aim.pdf#new_tab

BTW - the link in your 17.58 doesn't work either - if you notice it ain't gone blue as usual.

Perhaps you could kindly post the actual script from the Scancell website so I can read it, here or there.

C11 - always so innocent. Yes you are troublesome, off chord and impolite, (implying I'd been drinking, because the website didn't produce. I should be so lucky LOL).

Interestingly, Marcus posted a link over there and that doesn't work for me either - still obscured by the immoveable sign in. I'm on laptop - I wonder if it's working better on phones.

Cleaner I'll try that link tomorrow. Delayed by other things going on. Thanks.

C11 - none actually. Why are you so troublesome ?

Cleaner - thanks for a helpful reply and I'll try that later. ATB

C11 - Actually, 'News', then 'Latest News'. But when I get there, a half screen sign in feature obscures the script and I cant get rid of it. The site doesn't work for me !

Thanks for that WTP. Takes me back to what for me is that dreadful website - fancy graphics and poor functionality. I want to read the piece - can anyone copy it here please?

Cleaner thanks. Dr Nermeen Varawalla, our CMO, gets around doesn't she!

Obviously a significant appointment in July last year, I looked back at the July '24 RNS and noted these weighty comments - "a strong track record in the execution of global drug development programmes, including numerous registration studies in oncology" and "instrumental in driving transformational change to clinical development and was responsible for the design and execution of phase 3 clinical registration trials".

It's not that I was 'unimpressed' with her Appointment at the time, but lately I was surprised to see that CMO will be leading the charge at the coming AACR. Dr Nermeen really seems to be a 'shaker and mover' and I am somewhat reassured by her presence in the Scancell team.

Not to forget June 24-26 'Neoantigen Summit' where Dr Nermeen is highlighted as one of 6 'Expert Speakers' and mentioned in context with AZ and GSK speakers. Following the AACR meet, hopefully, ears will be open for her.

Good stuff, thanks.

Agreed WTP - that's the BB to read today, for Scancellites ! ATB

EE - a couple of weeks ago I took scinv off filter - but I quickly reinstated it. For me it's better that way. ATB

The second part of CRUK's review of cancer vaccines. I didn't pick up any reference to at all (?) to Scancell's remarkable progress - the interview deals almost exclusively with mRNA vaccines. Whilst CRUK have been helpful to Scancell in the past, atm I don't see much contribution to giving Scancell visibility, (even in Heather Shaw's contribution, our name was not mentioned).

Never mind, perhaps we'll get a mention in Part 3 ? Here it is :-

"What are cancer vaccines? Part 2 🔬 | That Cancer Conversation"

hTTps://youtu.be/dudq1x0LuaA

I recall, (but cannot now find), words from Prof. Lindy, reported by Inan, that Pharma are largely busy pursuing their own avenues but, that Scancell, are going to surprise !!!! Roll on the day . . .

Jambo - but it's only an 'opportunity missed', IF there IS 'new' data actually available. If there's no 'new' data, maybe some informal update on progress will be given.

From the RNS - " a potent, targeted DNA melanoma cancer vaccine, that effectively activates high-avidity T cells, leading to a potent, lasting immune response by creating an immune memory that prevents the cancer from recurring" - dynamite words. And iSCIB1+ to come!

EE re. this - "Why would the AACR give them a platform without new data?"

Could it be that for AACR, the data is 'new', not having been presented at AACR before? Also is it possible that an indicative update may be given or even words indicating the latest 'look' of the trial figures, if nothing else. But 'new' news, to us, would be nice.

Anyway, all good - we shall see . . . .

Cleaner, going back to 27/3, 11.01, I noted this - "85% fresh speaker faculty featuring experts from AilseBio, AstraZeneca, GSK, Scancell and more ".

Yes that 'experts'from AZ, GSK, Scancell and more. It's good to see Scancell mentioned in such elevated company. AZ, GSK, Scancell !

I also noted Nermeen CMO is one of 6 highlighted Speakers in the 'Intro'.

In itself, the mention may not be worth a bag of beans, but does it show that Scancell are perhaps beginning batter their way to some greater awareness/prominence?

Thanks both for the link - Heather Shaw starts talking about SCOPE at about 21 minutes.

No problem Violin. ATB

Hello Mia. I'm ok thanks (in Chantaburi). I WAS travelling tomorrow to Korat, 250km east of BKK, (1200km from Mandalay), but whilst no damage is reported yet in Korat, the massive Public Hospital was today emptied to the streets. So I've forgone my Hotel stay, (1km from there), on the 8th floor, to catch the football tomorrow. We were in the North, 700km from BKK 3 weeks ago, quake was felt up there. BKK is in disarray, Skytrain closed etc. But I dread to think about Mandalay, Myanmar being in a desperate state anyway. 7.7 is a mighty quake. God help and rest the poor Souls caught up in this. ATB

C11 - re. this, "However the old site looked like it was built by a student back in the mid-90s" - I couldn't disagree more. The old webite was easy to use and comprehensive. The new website is a massive step back and I find that ease of use has been sacrificed for irrelevant style and garaphics.

I'm with Ruck on this one. Never mind.

Yes Scin its Part 3 but it's not 'garbage'. Doesn't hurt to keep it there - some may have missed it and you never know, someone new might look in. An excellent interview with Ms. Shaw IMO.

Bob - useful repeat of that link, (posted by Johnny, March 18th 16.30).

Between 29-32 minutes - "Heather Shaw talks about other very exciting technologies, one specifically DNA but 'still of super technical background' and working in metastaic settings. These vaccines are not receiving all the Press attention that the mRNA vaccines are. She talks about the virtues of being able to 'lift a vial off a shelf rather than having to send bits of tumour to America' - (wow that's a high impact point is it not). The 'new build' of this DNA vaccine 'works for everybody' . . . " ATB